×
0.354838709677419 0.354838709677419 0.161290322580645 0.161290322580645 0.161290322580645 0.161290322580645 0.125774193548387 0.951612903225807
Stockreport

US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study

Immuron Ltd ADR (IMRN)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: immuron.com/investor-centre/business-overview
PDF Key Highlights: Travelan® shigellosis challenge studies in non-human primates successfully completedTravelan® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan® treated animals compared to placebo and demonstrated a significant clinical benefit Prophylactic administration of Travelan® may provide an effective prevention alternative to antibiotics for gastrointestinal infections in humansThree new Shigella specific anti-microbial therapeutics under preclinical evaluationA preventative treatment that protects against enteric diseases, specifically Shigella, is a high priority objective for the US Army MELBOURNE, Australia, June 12, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of many gut mediated pathogens, today is pleased to provide shareholders with an update on the company’s cooperative research and [Read more]

IMPACT SNAPSHOT EVENT TIME: IMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
IMRN alerts
from News Quantified
Opt-in for
IMRN alerts

from News Quantified
Opt-in for
IMRN alerts

from News Quantified